Casdin Capital, LLC Q2 2024 Filing
Filed August 14, 2024
Portfolio Value
$1.3B
Holdings
38
Report Date
Q2 2024
Filing Type
13F-HR
All Holdings (38 positions)
| # | Stock | Shares | Value | % Portfolio | Type |
|---|---|---|---|---|---|
| 1 | BLFSBIOLIFE SOLUTIONS INC | 8,707,165 | $186.6T | 14302871.47% | |
| 2 | RVMDREVOLUTION MEDICINES INC | 4,406,875 | $171.0T | 13109878.47% | |
| 3 | SRPTSAREPTA THERAPEUTICS INC | 1,073,500 | $169.6T | 13001199.61% | |
| 4 | FLBSTANDARD BIOTOOLS INC | 63,959,677 | $113.2T | 8677683.73% | |
| 5 | WGSGENEDX HOLDINGS CORP | 3,526,411 | $92.2T | 7065823.80% | |
| 6 | RNAAVIDITY BIOSCIENCES INC | 2,084,841 | $85.2T | 6528137.47% | |
| 7 | RLAYRELAY THERAPEUTICS INC | 8,448,574 | $55.1T | 4222360.35% | |
| 8 | ILMNILLUMINA INC | 480,000 | $50.1T | 3840456.23% | |
| 9 | NTLAINTELLIA THERAPEUTICS INC | 2,000,000 | $44.8T | 3430949.84% | |
| 10 | ALNYALNYLAM PHARMACEUTICALS INC | 170,000 | $41.3T | 3166499.95% | |
| 11 | 2L9BLUEPRINT MEDICINES CORP | 326,378 | $35.2T | 2696393.98% | |
| 12 | DNLIDENALI THERAPEUTICS INC | 1,300,000 | $30.2T | 2313821.53% | |
| 13 | GPCRSTRUCTURE THERAPEUTICS INC | 700,000 | $27.5T | 2107090.71% | |
| 14 | EXASEXACT SCIENCES CORP | 650,000 | $27.5T | 2105059.42% | |
| 15 | TNYATENAYA THERAPEUTICS INC | 6,732,971 | $20.9T | 1599899.59% | |
| 16 | NGNENEUROGENE INC | 524,616 | $19.1T | 1463348.86% | |
| 17 | VCYTVERACYTE INC | 857,904 | $18.6T | 1425023.09% | |
| 18 | FDMT4D MOLECULAR THERAPEUTICS IN | 800,000 | $16.8T | 1287142.75% | |
| 19 | BEAMBEAM THERAPEUTICS INC | 675,000 | $15.8T | 1212272.77% | |
| 20 | VERVVERVE THERAPEUTICS INC | 3,059,094 | $14.9T | 1144292.21% | |
| 21 | PLRXPLIANT THERAPEUTICS INC | 1,000,000 | $10.8T | 824010.52% | |
| 22 | TNGXTANGO THERAPEUTICS INC | 1,188,349 | $10.2T | 781547.84% | |
| 23 | IPSCCENTURY THERAPEUTICS INC | 3,206,380 | $8.2T | 626728.52% | |
| 24 | TSVT*2SEVENTY BIO INC | 2,000,000 | $7.7T | 590221.49% | |
| 25 | CDXSCODEXIS INC | 2,000,000 | $6.2T | 475243.27% | |
| 26 | CTNMCONTINEUM THERAPEUTICS INC | 296,666 | $5.2T | 400452.86% | |
| 27 | KYTXKYVERNA THERAPEUTICS INC | 575,000 | $4.3T | 330562.36% | |
| 28 | SNDXSYNDAX PHARMACEUTICALS INC | 150,000 | $3.1T | 236050.27% | |
| 29 | ABSIABSCI CORPORATION | 973,260 | $3.0T | 229775.60% | |
| 30 | GHGUARDANT HEALTH INC | 100,000 | $2.9T | 221371.38% | |
| 31 | PRMEPRIME MEDICINE INC | 367,175 | $1.9T | 144664.05% | |
| 32 | PACBPACIFIC BIOSCIENCES CALIF IN | 1,035,859 | $1.4T | 108779.12% | |
| 33 | GRALGRAIL INC | 79,999 | $1.2T | 94250.32% | |
| 34 | EXAIEUREXSCIENTIA PLC | 213,900 | $1.1T | 83619.05% | |
| 35 | GLUEMONTE ROSA THERAPEUTICS INC | 261,014 | $976.2B | 74827.21% | |
| 36 | DNAGINKGO BIOWORKS HOLDINGS INC | 1,459,747 | $488.0B | 37405.71% | |
| 37 | —SINGULAR GENOMICS SYSTEMS IN | 44,129 | $372.9B | 28582.82% | |
| 38 | KRON1USDKRONOS BIO INC | 123,839 | $153.6B | 11770.70% |